257 related articles for article (PubMed ID: 36497170)
21. Human papillomavirus 16E6 suppresses major histocompatibility complex class I by upregulating lymphotoxin expression in human cervical cancer cells.
Kim DH; Kim EM; Lee EH; Ji KY; Yi J; Park M; Kim KD; Cho YY; Kang HS
Biochem Biophys Res Commun; 2011 Jun; 409(4):792-8. PubMed ID: 21621523
[TBL] [Abstract][Full Text] [Related]
22. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
23. [Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].
Liu B; Wu ZN; Liu XY; Sun HK; Li Q; Lin CQ; Zeng L; Cui JF; Yu XH; Zhang X; Li L; Chen W
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):277-82. PubMed ID: 27087374
[TBL] [Abstract][Full Text] [Related]
24. Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillance.
Zehbe I; Höhn H; Pilch H; Neukirch C; Freitag K; Maeurer MJ
Int J Cancer; 2005 Dec; 117(5):807-15. PubMed ID: 15981207
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
Shen J; Gao LL; Zhang Y; Han LL; Wang JD
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
[No Abstract] [Full Text] [Related]
27. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
28. HPV subtypes and immunological parameters of cervical cancer in Iceland during two time periods, 1958-1960 and 1995-1996.
Mikaelsdottir EK; Benediktsdottir KR; Olafsdottir K; Arnadottir T; Ragnarsson GB; Olafsson K; Sigurdsson K; Kristjansdottir GS; Imsland AK; Ogmundsdottir HM; Rafnar T
Gynecol Oncol; 2003 Apr; 89(1):22-30. PubMed ID: 12694650
[TBL] [Abstract][Full Text] [Related]
29. Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach.
Kumar A; Yadav IS; Hussain S; Das BC; Bharadwaj M
Biologicals; 2015 Sep; 43(5):344-8. PubMed ID: 26212000
[TBL] [Abstract][Full Text] [Related]
30. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
Kovacic MB; Castle PE; Herrero R; Schiffman M; Sherman ME; Wacholder S; Rodriguez AC; Hutchinson ML; Bratti MC; Hildesheim A; Morales J; Alfaro M; Burk RD
Cancer Res; 2006 Oct; 66(20):10112-9. PubMed ID: 17047075
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK).
Powell N; Cuschieri K; Cubie H; Hibbitts S; Rosillon D; De Souza SC; Molijn A; Quint W; Holl K; Fiander A
J Clin Virol; 2013 Nov; 58(3):571-4. PubMed ID: 24051043
[TBL] [Abstract][Full Text] [Related]
32. Distribution of the most common types of HPV in Iranian women with and without cervical cancer.
Farahmand Z; Soleimanjahi H; Garshasbi M; Hasanzadeh M; Zafari E
Women Health; 2021 Jan; 61(1):73-82. PubMed ID: 32957835
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of Human Papillomavirus-Negative Compared to Human Papillomavirus-Positive Cervical Cancer.
Kugelman N; Siegler E; Mackuli L; Lavie O; Schmidt M; Shaked-Mishan P; Segev Y
J Low Genit Tract Dis; 2022 Apr; 26(2):115-121. PubMed ID: 34967775
[TBL] [Abstract][Full Text] [Related]
34. Age-related changes of the cervix influence human papillomavirus type distribution.
Castle PE; Jeronimo J; Schiffman M; Herrero R; Rodríguez AC; Bratti MC; Hildesheim A; Wacholder S; Long LR; Neve L; Pfeiffer R; Burk RD
Cancer Res; 2006 Jan; 66(2):1218-24. PubMed ID: 16424061
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.
Ghaderi M; Nikitina Zake L; Wallin K; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Hum Immunol; 2001 Oct; 62(10):1153-8. PubMed ID: 11600224
[TBL] [Abstract][Full Text] [Related]
37. Antigenic Peptide Prediction From E6 and E7 Oncoproteins of HPV Types 16 and 18 for Therapeutic Vaccine Design Using Immunoinformatics and MD Simulation Analysis.
Jabbar B; Rafique S; Salo-Ahen OMH; Ali A; Munir M; Idrees M; Mirza MU; Vanmeert M; Shah SZ; Jabbar I; Rana MA
Front Immunol; 2018; 9():3000. PubMed ID: 30619353
[TBL] [Abstract][Full Text] [Related]
38. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
39. Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer.
Burger EA; Kim JJ; Sy S; Castle PE
Clin Infect Dis; 2017 Sep; 65(6):893-899. PubMed ID: 28531261
[TBL] [Abstract][Full Text] [Related]
40. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
